Streptococcus thermophilus Csm Complex RNA Shredding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current CRISPR-Cas systems, particularly Type III-A, lack a clear understanding of their RNA-targeting mechanism and specificity, with limited in vitro reconstitution and functional characterization, hindering their application in RNA interference and modification.
Innovation Solution
The Streptococcus thermophilus Type III-A Csm complex is characterized for its RNA-targeting capability, with a minimal complex composition established, comprising Csm4 and multiple Csm3 subunits, demonstrating specific RNA cleavage at 6-nt intervals, and shown to be programmable for site-specific RNA modification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If Type III-A Csm complex is used for RNA targeting, then RNA cleavage activity is achieved, but the mechanism and specificity were not clearly understood
Solution Approach 1:
The patent segments the Csm complex into individual subunits (Csm2, Csm3, Csm4, Csm5, Cas10) and systematically determines the function of each component. By analyzing the minimal complex composition and identifying that Csm3 is the endoribonuclease subunit responsible for RNA cleavage, the patent resolves the mechanism understanding gap while maintaining RNA targeting capability.
2Productivity
If multiple copies of Csm3 subunits are present in the Csm complex, then multiple cuts occur at 6 nt intervals, but the cleavage pattern complexity increases
Solution Approach 1:
The patent demonstrates that the Csm complex performs self-measurement and self-cleavage at regular 6 nucleotide intervals along the target RNA. The multiple Csm3 subunits automatically space their cleavage activities at fixed intervals, creating a predictable shredding pattern without requiring external guidance, thus achieving high productivity with a regular rather than chaotic complexity.
3Reliability
If the Csm complex is used for RNA knock-out, then gene product elimination is achieved, but flexibility for knock-down is reduced
Solution Approach 1:
The patent changes the functional parameter of the Csm3 endoribonuclease subunit by introducing mutations (e.g., D33A mutation) that abolish or reduce cleavage activity. This allows the same Csm complex framework to be tuned between two states: wild-type Csm3 for complete RNA knock-out and mutated Csm3 for partial knock-down, providing versatility while maintaining reliable gene product elimination capability.
4Loss of information
If Type III-A Csm system is characterized in vitro, then functional understanding is improved, but limited reconstitution data was available
Solution Approach 1:
The patent performs preliminary in vitro reconstitution of the Csm complex with purified subunits and crRNA before conducting functional assays. By pre-assembling the complex with defined stoichiometry and verifying its RNA cleavage activity in a controlled in vitro environment, the patent generates comprehensive reconstitution data that enables subsequent functional characterization and application studies.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This characterization provides a novel tool for RNA interference, enabling efficient and programmable RNA knock-out or knock-down, with the Csm complex effectively targeting and cleaving RNA in a PAM-independent manner, offering flexibility through mutation of the Csm3 subunit for knock-down capabilities.
Implementation Method 1
The Csm3 protein, present in multiple copies in both Csm complexes, acts as endoribonuclease
Data Source
Figure 1A~1B
Figure 1C~1D
Figure 1E~1F
AI summary
A Type III-A CRISPR-Cas (St Csm) complex of Streptococcus thermophilus comprising crRNA, Csm4, and Csm3 and use for cleavage of RNA bearing a nucleotide sequence complementary to the crRNA, in vitro or in vivo. Methods for site-specific cleavage/shredding of a target RNA molecule using an RNA-guided RNA endonuclease comprising a minimal complex of crRNA, Csm4, and Csm3, and methods of RNA knock-down and RNA knock-out are disclosed. 999211.